This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis | MicrobiomeTrials
← Back to trials NCT07223138
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis ENROLLING_BY_INVITATION PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-11-13Est. Completion: 2028-02-04
Enrollment target: 1,560 participantsLocations Clinical Site, Avondale, Arizona, United States Clinical Site, Mesa, Arizona, United States Clinical Site, Phoenix, Arizona, United States Clinical Site, Scottsdale, Arizona, United States Clinical Site, Tucson, Arizona, United States Clinical Site, Jonesboro, Arkansas, United States Clinical Site, Upland, California, United States Clinical Site, Avon Park, Florida, United States Clinical Site, Clearwater, Florida, United States Clinical Site, Tampa, Florida, United States Clinical Site, Charlotte, North Carolina, United States Clinical Site, Leland, North Carolina, United States Clinical Site, Middleburg Heights, Ohio, United States Clinical Site, Duncansville, Pennsylvania, United States Clinical Site, Memphis, Tennessee, United States Clinical Site, Baytown, Texas, United States Clinical Site, Lubbock, Texas, United States Other microbiome trials you might be interested in Arthritis, Psoriatic
This is a study to demonstrate the clinical efficacy and safety of the nanobody® sonelokimab administered subcutaneously…
Rancho Mirage, United States Completed Sep 5, 2023
Psoriatic Arthritis
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasi…
Mesa, United States Est. completion May 18, 2027